{"hands_on_practices": [{"introduction": "This first practice grounds our understanding in the fundamental principles of molecular interaction. Before we can analyze complex signaling cascades, we must first quantify how a ligand binds to its receptor. This exercise guides you through deriving the essential relationship between ligand concentration, receptor affinity, and fractional occupancy from the law of mass action, providing the quantitative bedrock for interpreting nearly all dose-response data. [@problem_id:2581941]", "problem": "A single-compartment mammalian cell expresses a family of G protein-coupled receptors (GPCRs) with total receptor number per cell $R_T = 5 \\times 10^{4}$. A monovalent ligand binds to a single site on each receptor with dissociation constant $K_d = 20\\,\\mathrm{nM}$. The cell is bathed in a well-stirred extracellular medium that acts as a large reservoir at fixed bulk ligand concentration $[L]$, so that ligand depletion by binding to the receptors on one cell is negligible. Assume equilibrium, one-to-one noncooperative binding, and that downstream signaling scales with the fraction of receptors occupied up to pathway-specific thresholds.\n\nStarting only from the definition of the dissociation constant for the equilibrium reaction $\\mathrm{R} + \\mathrm{L} \\rightleftharpoons \\mathrm{RL}$ and the conservation of receptor number, derive an expression for the fractional receptor occupancy as a function of $[L]$ and $K_d$. Then, evaluate the fractional occupancy at $[L] = 5\\,\\mathrm{nM}$, $[L] = 20\\,\\mathrm{nM}$, and $[L] = 100\\,\\mathrm{nM}$. Finally, briefly interpret how these occupancies relate to possible downstream signaling thresholds and receptor reserve in GPCR pathways, without introducing any additional phenomenological formulas.\n\nReport the three fractional occupancies, in the order corresponding to $[L] = 5\\,\\mathrm{nM}$, $20\\,\\mathrm{nM}$, and $100\\,\\mathrm{nM}$, as unitless decimal fractions. Round each to four significant figures.", "solution": "The problem as stated is scientifically grounded, self-contained, and well-posed. It describes a classical equilibrium binding model, a fundamental concept in pharmacology and biophysics, which is directly formalizable using the law of mass action. The provided parameters are physically realistic, and the questions are unambiguous. Therefore, a solution may be derived.\n\nThe problem requires the derivation of an expression for fractional receptor occupancy. Let us begin from first principles.\n\nThe binding of a ligand $\\mathrm{L}$ to a receptor $\\mathrm{R}$ to form a complex $\\mathrm{RL}$ is described by the reversible reaction:\n$$\n\\mathrm{R} + \\mathrm{L} \\rightleftharpoons \\mathrm{RL}\n$$\nAt equilibrium, the rates of the forward and reverse reactions are equal. The dissociation constant, $K_d$, is defined by the ratio of the concentrations of the species at equilibrium:\n$$\nK_d = \\frac{[\\mathrm{R}][\\mathrm{L}]}{[\\mathrm{RL}]} \\quad (1)\n$$\nwhere $[\\mathrm{R}]$ is the concentration of free receptors, $[\\mathrm{L}]$ is the concentration of free ligand, and $[\\mathrm{RL}]$ is the concentration of ligand-receptor complexes.\n\nThe problem states the conservation of total receptors. Let the total concentration of receptors be $[R_T]$. This total concentration is the sum of the concentration of free receptors and the concentration of receptors bound to ligand:\n$$\n[R_T] = [\\mathrm{R}] + [\\mathrm{RL}] \\quad (2)\n$$\nFrom this conservation law, we can express the concentration of free receptors as:\n$$\n[\\mathrm{R}] = [R_T] - [\\mathrm{RL}] \\quad (3)\n$$\nSubstituting equation $(3)$ into the definition of the dissociation constant, equation $(1)$, we obtain:\n$$\nK_d = \\frac{([R_T] - [\\mathrm{RL}])[\\mathrm{L}]}{[\\mathrm{RL}]}\n$$\nOur goal is to derive an expression for the fractional receptor occupancy, $\\theta$, which is defined as the fraction of total receptors that are bound to ligand:\n$$\n\\theta = \\frac{[\\mathrm{RL}]}{[R_T]} \\quad (4)\n$$\nTo find this, we must first solve the expression for $K_d$ for the quantity $[\\mathrm{RL}]$.\n$$\nK_d [\\mathrm{RL}] = ([R_T] - [\\mathrm{RL}])[\\mathrm{L}]\n$$\n$$\nK_d [\\mathrm{RL}] = [R_T][\\mathrm{L}] - [\\mathrm{RL}][\\mathrm{L}]\n$$\n$$\nK_d [\\mathrm{RL}] + [\\mathrm{RL}][\\mathrm{L}] = [R_T][\\mathrm{L}]\n$$\n$$\n[\\mathrm{RL}] (K_d + [\\mathrm{L}]) = [R_T][\\mathrm{L}]\n$$\n$$\n[\\mathrm{RL}] = \\frac{[R_T][\\mathrm{L}]}{K_d + [\\mathrm{L}]} \\quad (5)\n$$\nNow, to find the fractional occupancy $\\theta$, we divide both sides of equation $(5)$ by $[R_T]$ as per definition $(4)$:\n$$\n\\theta = \\frac{[\\mathrm{RL}]}{[R_T]} = \\frac{1}{[R_T]} \\left( \\frac{[R_T][\\mathrm{L}]}{K_d + [\\mathrm{L}]} \\right)\n$$\nThis simplifies to the final derived expression for fractional occupancy, also known as the Hill-Langmuir equation for non-cooperative binding:\n$$\n\\theta = \\frac{[\\mathrm{L}]}{K_d + [\\mathrm{L}]}\n$$\nNote that the fractional occupancy $\\theta$ is independent of the total receptor number, $R_T$, a value which was given as $5 \\times 10^{4}$ but is not required for this part of the calculation.\n\nNext, we evaluate $\\theta$ for the given values. The dissociation constant is $K_d = 20\\,\\mathrm{nM}$.\n\nCase 1: Ligand concentration $[L] = 5\\,\\mathrm{nM}$.\n$$\n\\theta_1 = \\frac{5\\,\\mathrm{nM}}{20\\,\\mathrm{nM} + 5\\,\\mathrm{nM}} = \\frac{5}{25} = 0.2\n$$\nRounded to four significant figures, this is $0.2000$.\n\nCase 2: Ligand concentration $[L] = 20\\,\\mathrm{nM}$.\n$$\n\\theta_2 = \\frac{20\\,\\mathrm{nM}}{20\\,\\mathrm{nM} + 20\\,\\mathrm{nM}} = \\frac{20}{40} = 0.5\n$$\nThis result is expected, as the dissociation constant $K_d$ is defined as the ligand concentration at which half of the receptors are occupied. Rounded to four significant figures, this is $0.5000$.\n\nCase 3: Ligand concentration $[L] = 100\\,\\mathrm{nM}$.\n$$\n\\theta_3 = \\frac{100\\,\\mathrm{nM}}{20\\,\\mathrm{nM} + 100\\,\\mathrm{nM}} = \\frac{100}{120} = \\frac{5}{6} \\approx 0.833333...\n$$\nRounded to four significant figures, this is $0.8333$.\n\nFinally, we are asked to interpret these results in the context of signaling thresholds and receptor reserve.\nThe fractional occupancy values of $0.2000$, $0.5000$, and $0.8333$ represent the fraction of the total $5 \\times 10^{4}$ receptors that are active at each ligand concentration. Downstream signaling is initiated by these active receptors.\nA minimal fractional occupancy, or threshold, may be required to trigger a measurable cellular response. For example, if a pathway's threshold is $\\theta > 0.25$, a ligand concentration of $5\\,\\mathrm{nM}$ ($\\theta=0.2000$) would be insufficient to elicit a response, whereas $20\\,\\mathrm{nM}$ ($\\theta=0.5000$) would be sufficient.\nThe concept of \"receptor reserve\" or \"spare receptors\" relates to the observation that in many GPCR systems, a maximal biological response is achieved at a fractional occupancy significantly less than $1$. For instance, if this cell system were to exhibit its maximal response at $[L] = 20\\,\\mathrm{nM}$ (where $\\theta = 0.5000$), it would imply that only $50\\%$ of the total receptors need to be activated. The remaining $50\\%$ of unoccupied or redundant receptors constitute the receptor reserve. This reserve allows the cell to be highly sensitive, producing a maximal effect at a ligand concentration far below that required for receptor saturation. Conversely, if a maximal response required a high ligand concentration, such as $[L] = 100\\,\\mathrm{nM}$ or greater, this would indicate a small or negligible receptor reserve, where the signaling response is more directly proportional to the total number of occupied receptors. Without experimental data on the cellular response, we can only state these as possibilities conditioned on the relationship between occupancy and response.", "answer": "$$\\boxed{\\begin{pmatrix} 0.2000 & 0.5000 & 0.8333 \\end{pmatrix}}$$", "id": "2581941"}, {"introduction": "Building upon the concept of receptor occupancy, this practice explores the crucial, and often non-linear, relationship between binding and the ultimate physiological response. It introduces the concepts of intrinsic efficacy ($\\epsilon$) and receptor reserve, which explain why a maximal cellular effect can often be achieved without occupying every available receptor. By working through this hypothetical scenario, you will gain insight into how a ligand classified as a \"partial agonist\" can, in some systems, behave as a full agonist, a critical distinction in drug development. [@problem_id:2581932]", "problem": "In a physiological tissue expressing a single class of membrane receptors, the graded response to an agonist is normalized so that the maximal attainable system response equals $1$. Let the fractional receptor occupancy be given by the classic mass-action relation $\\theta = \\frac{[A]}{[A] + K_{d}}$, where $[A]$ is agonist concentration and $K_{d}$ is the dissociation constant. Define the stimulus generated by the agonist as proportional to the product of its intrinsic efficacy $\\epsilon$ and the fractional occupancy $\\theta$. The tissue possesses a receptor reserve: a full agonist (intrinsic efficacy $\\epsilon = 1$) elicits the maximal system response when only a fraction $f_{\\mathrm{req}}$ of receptors are occupied. The receptor reserve fraction is $0.6$, meaning only $1 - 0.6 = 0.4$ of receptors must be occupied by a full agonist to achieve the maximal system response.\n\nA test ligand is a partial agonist with intrinsic efficacy $\\epsilon = 0.4$ and dissociation constant $K_{d} = 50 \\ \\mathrm{nM}$. Working from first principles of receptor occupancy and the definition of receptor reserve stated above, determine the maximal response this partial agonist can achieve relative to the full agonist’s maximal system response, when concentration $[A]$ is allowed to vary over all positive values.\n\nExpress your final answer as a unitless decimal ratio and round to four significant figures.", "solution": "The problem will be validated against the required criteria before a solution is attempted.\n\n**Step 1: Extract Givens**\n- The maximal attainable system response is normalized to $1$.\n- The fractional receptor occupancy is given by the relation $\\theta = \\frac{[A]}{[A] + K_{d}}$, where $[A]$ is the agonist concentration and $K_{d}$ is the dissociation constant.\n- The stimulus, $S$, is proportional to the product of intrinsic efficacy, $\\epsilon$, and fractional occupancy, $\\theta$. This can be written as $S = k \\epsilon \\theta$ for some proportionality constant $k$.\n- A full agonist is defined as having an intrinsic efficacy of $\\epsilon_{\\text{full}} = 1$.\n- The tissue has a receptor reserve fraction of $0.6$. This means that a full agonist elicits the maximal system response when the fraction of occupied receptors is $f_{\\mathrm{req}} = 1 - 0.6 = 0.4$.\n- A test ligand is a partial agonist with intrinsic efficacy $\\epsilon_{\\text{p}} = 0.4$.\n- The dissociation constant for this partial agonist is $K_{d, \\text{p}} = 50 \\ \\mathrm{nM}$.\n- The objective is to find the maximal response of the partial agonist relative to the maximal system response, rounded to four significant figures.\n\n**Step 2: Validate Using Extracted Givens**\nThe problem is assessed for validity:\n- **Scientifically Grounded:** The problem is based on the classical pharmacological theory of drug-receptor interaction, specifically the concepts of receptor occupancy, intrinsic efficacy, stimulus-response coupling, and receptor reserve. These are established principles in physiology and pharmacology. The problem is scientifically sound.\n- **Well-Posed:** The problem provides a clear set of definitions and quantitative values to determine a specific output. The objective is unambiguous. The information provided is sufficient to arrive at a unique solution.\n- **Objective:** The problem is stated in precise, technical language, free of subjective or ambiguous terminology.\n\nThe problem does not violate any of the invalidity criteria. The inclusion of the dissociation constant $K_{d, \\text{p}}$ is extraneous to the calculation of the maximal response ($E_{\\max}$), but its presence does not invalidate the problem; it merely tests the understanding of which parameters are relevant. The problem is deemed valid.\n\n**Step 3: Verdict and Action**\nThe problem is valid. A reasoned solution will now be provided.\n\n**Solution**\nThe relationship between agonist binding and tissue response can be modeled by a two-step process: the generation of a stimulus, followed by the transduction of that stimulus into a measurable response.\n\nLet $S$ be the stimulus generated by an agonist. According to the problem statement, the stimulus is proportional to the product of the agonist's intrinsic efficacy, $\\epsilon$, and the fractional receptor occupancy, $\\theta$. We can express this relationship as:\n$$S = k \\epsilon \\theta$$\nwhere $k$ is a constant of proportionality that accounts for factors such as total receptor density.\n\nLet $R$ be the normalized system response, which is a function of the stimulus, $R = f(S)$. The function $f(S)$ is a monotonically increasing function, with $f(0) = 0$ and a maximum value of $1$.\n\nWe are given that a full agonist, with $\\epsilon_{\\text{full}} = 1$, elicits the maximal system response, $R=1$, when the fractional occupancy is $\\theta = f_{\\mathrm{req}} = 0.4$. This information allows us to determine the minimum stimulus required to achieve the maximal response. Let us denote this threshold stimulus as $S_{\\text{req}}$.\n$$S_{\\text{req}} = k \\cdot \\epsilon_{\\text{full}} \\cdot f_{\\mathrm{req}} = k \\cdot (1) \\cdot (0.4) = 0.4k$$\nThe properties of the stimulus-response function $f(S)$ are such that for any stimulus $S \\geq S_{\\text{req}}$, the response is maximal, i.e., $f(S) = 1$.\n\nNext, we analyze the test ligand, which is a partial agonist with an intrinsic efficacy of $\\epsilon_{\\text{p}} = 0.4$. We need to determine the maximal response, $R_{\\text{p,max}}$, that this ligand can produce. The maximal response occurs at the maximal possible stimulus, $S_{\\text{p,max}}$, that the ligand can generate.\n\nThe maximal stimulus is achieved when the concentration of the agonist, $[A]$, is saturating ($[A] \\to \\infty$). At saturating concentrations, the fractional receptor occupancy, $\\theta$, approaches its maximum value of $1$.\n$$\\theta_{\\text{max}} = \\lim_{[A]\\to\\infty} \\frac{[A]}{[A] + K_{d}} = 1$$\nNote that this maximal occupancy does not depend on the value of the dissociation constant, $K_{d}$. Therefore, the given value of $K_{d, \\text{p}} = 50 \\ \\mathrm{nM}$ is not required to find the maximal response.\n\nThe maximal stimulus producible by the partial agonist is:\n$$S_{\\text{p,max}} = k \\cdot \\epsilon_{\\text{p}} \\cdot \\theta_{\\text{max}} = k \\cdot (0.4) \\cdot (1) = 0.4k$$\n\nNow, we compare the maximal stimulus from the partial agonist, $S_{\\text{p,max}}$, with the stimulus required for a maximal system response, $S_{\\text{req}}$.\n$$S_{\\text{p,max}} = 0.4k$$\n$$S_{\\text{req}} = 0.4k$$\nWe find that $S_{\\text{p,max}} = S_{\\text{req}}$.\n\nThe maximal response of the partial agonist is the response generated by its maximal stimulus:\n$$R_{\\text{p,max}} = f(S_{\\text{p,max}})$$\nSince $S_{\\text{p,max}} = S_{\\text{req}}$, and we know that any stimulus equal to or greater than $S_{\\text{req}}$ produces the maximal system response of $1$, it follows that:\n$$R_{\\text{p,max}} = f(S_{\\text{req}}) = 1$$\nThis result demonstrates that in a system with a significant receptor reserve, a ligand that is classified as a partial agonist (based on its intrinsic efficacy $\\epsilon < 1$) can still function as a full agonist, capable of eliciting the maximal possible tissue response.\n\nThe problem asks for the maximal response of the partial agonist relative to the full agonist's maximal system response. The maximal system response is normalized to $1$. The calculated maximal response for the partial agonist is also $1$. The ratio is therefore:\n$$\\text{Ratio} = \\frac{R_{\\text{p,max}}}{R_{\\text{max\\_sys}}} = \\frac{1}{1} = 1$$\n\nAs required, we express this answer as a decimal ratio rounded to four significant figures.", "answer": "$$\\boxed{1.000}$$", "id": "2581932"}, {"introduction": "Our final practice moves into the advanced realm of modern receptor theory, tackling situations where receptors are active even in the absence of a ligand. Using the powerful Black–Leff operational model, this problem explores the phenomena of constitutive activity ($\\tau_0$) and inverse agonism, where a ligand acts to reduce this basal signaling. This exercise is key to understanding the pharmacology of many diseases caused by receptor mutations and the mechanism of drugs designed to quiet overactive signaling pathways. [@problem_id:2581917]", "problem": "A constitutively active mutation in a G protein-coupled receptor (GPCR) increases baseline signaling in the absence of ligand. In the Black–Leff operational framework, the transduction mechanism is summarized by a dimensionless stimulus variable $S$ that determines the response $E$ by the saturating transform $E = E_{\\max}\\,\\dfrac{S}{1+S}$. In the absence of ligand, constitutive activity is represented as a basal stimulus $S_0 = \\tau_0$, producing a basal response $E_0 = E_{\\max}\\,\\dfrac{\\tau_0}{1+\\tau_0}$. A ligand with efficacy is modeled to contribute an additional stimulus term that depends on its occupancy. For a ligand $L$ at concentration $[L]$ with affinity constant $K_L$ and operational efficacy parameter $\\tau_L$, the stimulus addition is $\\sigma_L = \\tau_L\\,\\dfrac{[L]}{K_L + [L]}$, so that the total stimulus is $S = \\tau_0 + \\sigma_L$. An inverse agonist is a ligand with $\\tau_I &lt; 0$, reducing the total stimulus below $\\tau_0$ by stabilizing the inactive receptor ensemble.\n\nUsing only the definitions above and first principles of receptor occupancy and transduction as stated, derive the total stimulus $S$ required to reduce the basal response to a fraction $r = 0.2$ of its baseline value (that is, reduce to $0.2$ times $E_0$), and use this to obtain the inverse agonist occupancy needed. Then, given an inverse agonist with operational efficacy parameter $\\tau_I$ and applied concentration $[I]$, compute the affinity constant $K_i$ required to achieve the target reduction using the occupancy relation $\\dfrac{[I]}{K_i + [I]}$.\n\nNumerical specification for calculation:\n- Basal transduction ratio: $\\tau_0 = 0.5$.\n- Inverse agonist efficacy: $\\tau_I = -1.0$.\n- Applied inverse agonist concentration: $[I] = 30.00$ nM.\n\nExpress the final $K_i$ in molar (M). Round your answer to four significant figures.", "solution": "The problem is first validated for scientific soundness, consistency, and completeness.\n\nStep 1: Extract Givens.\n- Response-stimulus relationship: $E = E_{\\max}\\,\\dfrac{S}{1+S}$\n- Basal stimulus (constitutive activity): $S_0 = \\tau_0$\n- Basal response: $E_0 = E_{\\max}\\,\\dfrac{\\tau_0}{1+\\tau_0}$\n- Stimulus from ligand $L$: $\\sigma_L = \\tau_L\\,\\dfrac{[L]}{K_L + [L]}$\n- Total stimulus with ligand: $S = \\tau_0 + \\sigma_L$\n- Inverse agonist is a ligand with operational efficacy $\\tau_I < 0$.\n- Target response is a fraction $r = 0.2$ of the basal response $E_0$.\n- Inverse agonist concentration: $[I]$\n- Inverse agonist affinity constant: $K_i$\n- Inverse agonist efficacy: $\\tau_I$\n- Stimulus from inverse agonist $I$: $\\sigma_I = \\tau_I\\,\\dfrac{[I]}{K_i + [I]}$\n- Total stimulus with inverse agonist: $S = \\tau_0 + \\sigma_I$\n- Occupancy relation for inverse agonist: $\\dfrac{[I]}{K_i + [I]}$\n- Numerical values: $\\tau_0 = 0.5$, $\\tau_I = -1.0$, $[I] = 30.00$ nM.\n\nStep 2: Validate Using Extracted Givens.\nThe problem is scientifically grounded, utilizing the established Black–Leff operational model of receptor pharmacology. The concepts of constitutive activity, efficacy, affinity, and inverse agonism are standard in the field. The problem is well-posed, providing all necessary definitions, equations, and numerical values to derive a unique solution. The language is objective and precise. The numerical values are physically plausible for a biological system. The problem is self-contained and free of contradictions.\n\nStep 3: Verdict and Action.\nThe problem is valid. A reasoned solution will be provided.\n\nThe objective is to find the affinity constant $K_i$ of an inverse agonist required to reduce the basal response to a specified level.\n\nFirst, we establish the relationship between the target stimulus, which we will call $S_{target}$, and the basal stimulus parameter, $\\tau_0$. The basal response is given as $E_0 = E_{\\max}\\,\\dfrac{\\tau_0}{1+\\tau_0}$. The target response, $E_{target}$, is a fraction $r$ of the basal response, so $E_{target} = r \\cdot E_0$.\nThe target response is produced by the target stimulus $S_{target}$ according to the same transduction function: $E_{target} = E_{\\max}\\,\\dfrac{S_{target}}{1+S_{target}}$.\nBy substituting the expressions for $E_0$ and $E_{target}$, we obtain the equation:\n$$E_{\\max}\\,\\dfrac{S_{target}}{1+S_{target}} = r \\cdot \\left( E_{\\max}\\,\\dfrac{\\tau_0}{1+\\tau_0} \\right)$$\nThe maximal response term $E_{\\max}$ cancels from both sides, provided $E_{\\max} \\neq 0$:\n$$\\dfrac{S_{target}}{1+S_{target}} = r\\,\\dfrac{\\tau_0}{1+\\tau_0}$$\nWe must solve this equation for $S_{target}$. Let $C = r\\,\\dfrac{\\tau_0}{1+\\tau_0}$. The equation becomes $\\dfrac{S_{target}}{1+S_{target}} = C$.\nRearranging for $S_{target}$:\n$$S_{target} = C(1+S_{target})$$\n$$S_{target} = C + C \\cdot S_{target}$$\n$$S_{target} - C \\cdot S_{target} = C$$\n$$S_{target}(1-C) = C$$\n$$S_{target} = \\dfrac{C}{1-C}$$\nNow, we substitute the expression for $C$ back into this equation:\n$$S_{target} = \\dfrac{r\\,\\dfrac{\\tau_0}{1+\\tau_0}}{1 - r\\,\\dfrac{\\tau_0}{1+\\tau_0}} = \\dfrac{r\\,\\tau_0}{(1+\\tau_0) - r\\,\\tau_0} = \\dfrac{r\\,\\tau_0}{1 + \\tau_0(1-r)}$$\nUsing the given numerical values $\\tau_0 = 0.5$ and $r = 0.2$:\n$$S_{target} = \\dfrac{0.2 \\cdot 0.5}{1 + 0.5(1-0.2)} = \\dfrac{0.1}{1 + 0.5(0.8)} = \\dfrac{0.1}{1 + 0.4} = \\dfrac{0.1}{1.4} = \\dfrac{1}{14}$$\nThis is the total stimulus required to achieve the target response reduction.\n\nNext, we relate this total stimulus to the properties of the inverse agonist. The total stimulus in the presence of the inverse agonist $I$ is given by $S = \\tau_0 + \\sigma_I$. For our target condition, $S = S_{target}$. The stimulus contribution from the inverse agonist is $\\sigma_I = \\tau_I \\cdot O_I$, where $O_I$ is the receptor occupancy by the inverse agonist, defined as $O_I = \\dfrac{[I]}{K_i + [I]}$.\nTherefore, we have the equation:\n$$S_{target} = \\tau_0 + \\tau_I \\cdot O_I$$\nWe can solve for the required occupancy $O_I$:\n$$O_I = \\dfrac{S_{target} - \\tau_0}{\\tau_I}$$\nSubstituting the numerical values $S_{target} = 1/14$, $\\tau_0 = 0.5 = 1/2$, and $\\tau_I = -1.0$:\n$$O_I = \\dfrac{\\frac{1}{14} - \\frac{1}{2}}{-1.0} = \\dfrac{\\frac{1}{14} - \\frac{7}{14}}{-1} = \\dfrac{-\\frac{6}{14}}{-1} = \\dfrac{6}{14} = \\dfrac{3}{7}$$\nSo, an occupancy of $3/7$ is required to achieve the desired reduction in signaling.\n\nFinally, we use the occupancy definition to solve for the affinity constant $K_i$.\n$$O_I = \\dfrac{[I]}{K_i + [I]}$$\nRearranging to solve for $K_i$:\n$$O_I(K_i + [I]) = [I]$$\n$$O_I \\cdot K_i + O_I \\cdot [I] = [I]$$\n$$O_I \\cdot K_i = [I](1 - O_I)$$\n$$K_i = [I] \\cdot \\dfrac{1 - O_I}{O_I}$$\nNow, we insert the known values: $[I] = 30.00$ nM and $O_I = 3/7$.\n$$K_i = (30.00 \\text{ nM}) \\cdot \\dfrac{1 - \\frac{3}{7}}{\\frac{3}{7}} = (30.00 \\text{ nM}) \\cdot \\dfrac{\\frac{4}{7}}{\\frac{3}{7}} = (30.00 \\text{ nM}) \\cdot \\frac{4}{3}$$\n$$K_i = 40.00 \\text{ nM}$$\nThe problem requires the answer in Molar (M). Since $1$ nM $= 10^{-9}$ M:\n$$K_i = 40.00 \\times 10^{-9} \\text{ M}$$\nExpressing this in standard scientific notation with four significant figures, as specified by the precision of the input value $[I]$:\n$$K_i = 4.000 \\times 10^{-8} \\text{ M}$$\nThis completes the derivation.", "answer": "$$\\boxed{4.000 \\times 10^{-8}}$$", "id": "2581917"}]}